×
Customizations Possible - Country-wise reports, Additional company profiles, Country/Regional reports and Other Customizations. Special Discounts Available. Positron Emission Tomography (PET) Market Size Report Segmented by Product (Standalone, PET/CT, PET/MRI), Application (Oncology, Neurology, Cardiology, Infectious Diseases), End User (Hospitals, Hospitals, Diagnostic Imaging Centers, ASCs) Forecasts to 2030

Positron Emission Tomography (PET) Market Size Report Segmented by Product (Standalone, PET/CT, PET/MRI), Application (Oncology, Neurology, Cardiology, Infectious Diseases), End User (Hospitals, Hospitals, Diagnostic Imaging Centers, ASCs) Forecasts to 2030

The global Positron Emission Tomography (PET) market is set to witness a growth rate of 5% in the next 5 years. Growing prevalence of chronic diseases; technological advancements in radiopharmaceuticals and PET systems; increasing demand for early and precise diagnosis; rising applications in oncology and neurology; and increasing investments, funds, and grants by public-private organizations are some of the key factors driving the PET market. To learn more about the research report, download a sample report.

Report Overview

PET is a sophisticated imaging technique used primarily in medical diagnostics. It employs a radioactive substance known as a radiotracer, which is injected into the patient's bloodstream. As the radiotracer accumulates in tissues, it emits positrons that are detected by a PET scanner, creating detailed images of metabolic activity within the body. This allows healthcare providers to identify abnormalities such as tumors, assess heart function, and evaluate brain disorders. PET scans are particularly valuable for detecting diseases at early stages, often before they are visible through other imaging methods like CT or MRI scans.

To learn more about the research report, download a sample report.

Technological advancements in radiopharmaceuticals and PET systems to propel market demand

Technological advancements in radiopharmaceuticals are significantly driving the growth of the PET market. The development of novel radiotracers, such as Gallium-68 and Fluorine-18-labeled compounds, has expanded PET applications beyond oncology to neurology, cardiology, and infectious diseases. These advancements enhance diagnostic accuracy by targeting specific biomarkers, enabling early and precise disease detection. Improved radiotracer production technologies, such as automated synthesis systems and compact cyclotrons, ensure a steady supply of high-quality radiopharmaceuticals, even in remote areas. This progress supports the growing demand for PET imaging in personalized medicine, further boosting its adoption across healthcare systems globally.

To learn more about the research report, download a sample report.

Rising applications in oncology and neurology are driving the market growth

Rising applications in oncology and neurology are key drivers of the PET market. In oncology, PET is invaluable for detecting, staging, and monitoring various cancers, offering precise insights into tumor activity and treatment effectiveness. Radiotracers like FDG enable early cancer detection and help tailor therapies. In neurology, PET aids in diagnosing neurodegenerative disorders such as Alzheimer’s and Parkinson’s by visualizing brain metabolism and amyloid plaques. It also helps assess epilepsy and monitor responses to neurological treatments. These expanding applications highlight PET’s role in improving clinical outcomes, driving its adoption in advanced diagnostic and therapeutic practices.

Competitive Landscape Analysis

The global positron emission tomography (PET) market is marked by the presence of established and emerging market players such as GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers, Shimadzu Corporation, Canon Medical Systems Corporation, Neusoft Medical Systems Co., Ltd., Oncovision, Positron, MinFound Medical Systems Co., Ltd, and CMR Naviscan; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Report Scope

Report Scope

Details

Base Year Considered

2024

Historical Data

2023 - 2024

Forecast Period

2025 - 2030

Growth Rate

5%

Market Drivers

  • Growing prevalence of chronic diseases
  • Technological advancements in radiopharmaceuticals and PET systems
  • Increasing demand for early and precise diagnosis
  • Rising applications in oncology and neurology

Attractive Opportunities

  • Emerging applications in cardiology and infectious diseases
  • Development of novel radiotracers
  • Expanding use in precision medicine

Segment Scope

Product, Application, End User

Regional Scope

  • North America (US & Canada)
  • Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
  • Asia Pacific (China, India, Japan, Rest of Asia Pacific)
  • Latin America
  • Middle East & Africa

Key Companies Mapped

GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers, Shimadzu Corporation, Canon Medical Systems Corporation, Neusoft Medical Systems Co., Ltd., Oncovision, Positron, MinFound Medical Systems Co., Ltd, and CMR Naviscan among others

Report Highlights

Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Market Segmentation

This report by Medi-Tech Insights provides the size of the global positron emission tomography (PET) market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, application, end user.

  • Market Size & Forecast (2023-2030), By Product, USD Million
    • Standalone PET Systems
    • PET/CT Systems
      • Low-Slice Scanners
      • Medium-Slice Scanners
      • High-Slice Scanners
    • PET/MRI Systems
  • Market Size & Forecast (2023-2030), By Application, USD Million
    • Oncology
    • Neurology
    • Cardiology
    • Infectious Diseases
    • Others
  • Market Size & Forecast (2023-2030), By End User, USD Million
    • Hospitals
    • Diagnostic Imaging Centers
    • Ambulatory Surgical Centers (ASCs)
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

Key Strategic Questions Addressed

  • What is the market size & forecast of the Positron Emission Tomography (PET) market?
  • What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the Positron Emission Tomography (PET) market?
  • What are the key trends defining the market?
  • What are the major factors impacting the market?
  • What are the opportunities prevailing in the market?
  • Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
  • Who are the major players operating in the market?
  • What are the key strategies adopted by players?
  • Introduction
    • Introduction​
    • Market Scope​
      • Market Definition​
      • Segments Covered​
      • Regional Segmentation​
    • Research Timeframe​
    • Currency Considered​
    • Study Limitations​
    • Stakeholders​
    • List of Abbreviations​
    • Key Conferences and Events (2025-2026)​
  • Research Methodology​
    • Secondary Research​
    • Primary Research​
    • Market Estimation​
      • Bottom-Up Approach​
      • Top-Down Approach​
    • Market Forecasting​
  • Executive Summary
    • Positron Emission Tomography (PET) Market Snapshot (2025-2030)​
    • Segment Overview​
    • Regional Snapshot​
    • Competitive Insights ​
  • Market Overview
    • Market Dynamics
    • Drivers
      • Growing prevalence of chronic diseases
      • Technological advancements in radiopharmaceuticals and PET systems
      • Increasing demand for early and precise diagnosis
      • Rising applications in oncology and neurology
      • Increasing investments, funds, and grants by public-private organizations  
    • Restraints​
      • High capital and operational costs of PET Systems
      • Stringent regulations for radiopharmaceuticals and imaging systems
      • Radiation exposure concerns
    • Opportunities​
      • Emerging applications in cardiology and infectious diseases
      • Development of novel radiotracers
      • Expanding use in precision medicine
    • Key Market Trends​
      • Hybrid imaging systems (PET/CT and PET/MRI)
      • AI and machine learning in PET IMAGING)
      • Miniaturized and portable PET scanners
    • Unmet Market Needs​
    • Industry Speaks​
  • Global Positron Emission Tomography (PET) Market Size & Forecast (2023-2030), By Product, USD Million
    • Introduction​
    • Standalone PET Systems
    • PET/CT Systems
      • Low-Slice Scanners
      • Medium-Slice Scanners
      • High-Slice Scanners
    • PET/MRI Systems
  • Global Positron Emission Tomography (PET) Market Size & Forecast (2023-2030), By Application, USD Million
    • Oncology
    • Neurology
    • Cardiology
    • Infectious Diseases
    • Others
  • Global Positron Emission Tomography (PET) Market Size & Forecast (2023-2030), By End User, USD Million​
    • Introduction
    • Hospitals
    • Diagnostic Imaging Centers
    • Ambulatory Surgical Centers (ASCs)
    • Others
  • Global Positron Emission Tomography (PET) Market Size & Forecast (2023-2030), By Region, USD Million
    • Introduction​
    • North America Positron Emission Tomography (PET) Market Size & Forecast (2023-2030), By Country, USD Million​
      • US​
        • Market Size & Forecast, By Product (USD Million)​
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By End User (USD Million)​
      • Canada​
        • Market Size & Forecast, By Product (USD Million)​
        • Market Size & Forecast, By Application (USD Million)​
        • Market Size & Forecast, By End User (USD Million)​
    • Europe Positron Emission Tomography (PET) Market Size & Forecast (2023-2030), By Country, USD Million​
      • UK ​
        • Market Size & Forecast, By Product (USD Million)​
        • Market Size & Forecast, By Application (USD Million)​
        • Market Size & Forecast, By End User (USD Million)​
      • Germany ​
        • Market Size & Forecast, By Product (USD Million)​
        • Market Size & Forecast, By Application (USD Million)​
        • Market Size & Forecast, By End User (USD Million)​
      • France ​
        • Market Size & Forecast, By Product (USD Million)​
        • Market Size & Forecast, By Application (USD Million)​
        • Market Size & Forecast, By End User (USD Million)​
      • Italy ​
        • Market Size & Forecast, By Product (USD Million)​
        • Market Size & Forecast, By Application (USD Million)​
        • Market Size & Forecast, By End User (USD Million)​
      • Spain ​
        • Market Size & Forecast, By Product (USD Million)​
        • Market Size & Forecast, By Application (USD Million)​
        • Market Size & Forecast, By End User (USD Million)​
      • Rest of Europe ​
        • Market Size & Forecast, By Product (USD Million)​
        • Market Size & Forecast, By Application (USD Million)​
        • Market Size & Forecast, By End User (USD Million)​
    • Asia Pacific (APAC) Positron Emission Tomography (PET) Market Size & Forecast (2023-2030), By Country, USD Million​
      • China ​
        • Market Size & Forecast, By Product (USD Million)​
        • Market Size & Forecast, By Application (USD Million)​
        • Market Size & Forecast, By End User (USD Million)​
      • Japan ​
        • Market Size & Forecast, By Product (USD Million)​
        • Market Size & Forecast, By Application (USD Million)​
        • Market Size & Forecast, By End User (USD Million)​
      • India ​
        • Market Size & Forecast, By Product (USD Million)​
        • Market Size & Forecast, By Application (USD Million)​
        • Market Size & Forecast, By End User (USD Million)​
      • Rest of Asia Pacific ​
        • Market Size & Forecast, By Product (USD Million)​
        • Market Size & Forecast, By Application (USD Million)​
        • Market Size & Forecast, By End User (USD Million)​
    • Latin America (LATAM) Positron Emission Tomography (PET) Market Size & Forecast (2023-2030), USD Million​
      • Market Size & Forecast, By Product (USD Million)​
      • Market Size & Forecast, By Application (USD Million)​
      • Market Size & Forecast, By End User (USD Million)​
    • Middle East & Africa (MEA) Positron Emission Tomography (PET) Market Size & Forecast (2023-2030), USD Million​
      • Market Size & Forecast, By Product (USD Million)​
      • Market Size & Forecast, By Application (USD Million)​
      • Market Size & Forecast, By End User (USD Million)​
  • Competitive Landscape
    • Key Players and their Competitive Positioning
      • Key Player Comparison
      • Segment-wise Player Mapping
      • Market Share Analysis (2024)
      • Company Categorization Matrix
        • Dominants/Leaders
        • New Entrants
        • Emerging Players
        • Innovative Players
    • Key Strategies Assessment, By Player (2022-2025)
      • New Product Launches
      • Partnerships, Agreements, & Collaborations
      • Mergers & Acquisitions
      • Geographic Expansion
  • Company Profiles* (Business Overview, Financial Performance**, Products Offered, Recent Developments)
    • GE HealthCare
    • Koninklijke Philips N.V.
    • Siemens Healthineers
    • Shimadzu Corporation
    • Canon Medical Systems Corporation
    • Neusoft Medical Systems Co., Ltd.
    • Oncovision
    • Positron
    • MinFound Medical Systems Co., Ltd
    • CMR Naviscan
    • Other Prominent Players

   Note: *Indicative list

   **For listed companies

The study has been compiled based on extensive primary and secondary research.

Secondary Research (Indicative List)

Primary Research

To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.

Supply Side Stakeholders:

  • Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
  • Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants

Demand Side Stakeholders:

  • Stakeholders from Hospitals; Diagnostic Imaging Centers; Ambulatory Surgical Centers (ASCs); and Others

Breakdown of Primary Interviews

Market Size Estimation

Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts

Data Triangulation

Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data